Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our UK Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS

  2. Font size

    Reduce font size Increase font size  
 
 

Site map

Contact us

Sanofi UK

One Onslow Street
Guildford
Surrey
GU1 4YS

Tel: 01483 505 515
Fax: 01483 535 432

 

Content :

Site map

  1. About Us
    1. Who we are
      1. 2011 Key Figures
      2. History
    2. Growth Platforms
    3. Sanofi in the UK
    4. Our Values
    5. Access Map
      1. Guildford
      2. Dagenham
      3. Holmes Chapel
      4. Fawdon
      5. Chapeltown
  2. Our Activities
    1. Key therapy areas
      1. Diabetes
      2. Oncology
      3. Cardiovascular/Thrombosis
      4. Renal
      5. Biosurgery
      6. Central Nervous System
      7. Internal Medicine
    2. Vaccines
    3. Generics
    4. Consumer Healthcare (OTC)
    5. Animal Health
    6. Industrial Infrastructure
  3. Our Products
  4. Research & Development
    1. Pipeline
    2. Partnerships
    3. Biotechnology
    4. Animal Welfare
  5. Our Responsibility
    1. Sanofi Inspires
    2. Sustainability
    3. Access to Health
      1. Counterfeit Medicines
    4. Humanitarian Partnerships
    5. Stakeholder Engagement
      1. Healthcare Professionals
      2. Working with Government and Policy Makers
    6. Working in Partnership
      1. Patient Associations
      2. Community Support
      3. 2013 Patient Group Bursary
      4. Quality in Care Programme
    7. Public Declaration of Payments
      1. Healthcare Organisation Payments
  6. Careers
  7. Press Room
    1. Press releases 2013
    2. Press releases 2012
    3. Press releases 2011
    4. Press releases 2010
    5. Press releases 2009
    6. Press releases 2008
    7. Press releases 2007
  8. Healthcare Professionals

Module :

Corporate Information

Corporate Information

 

Latest News

May 01, 2013

Lyxumia▼® (lixisenatide) - effective new Type 2 diabetes treatment could save the NHS millions offering value and choice